Search Medical Condition
Please enter condition
Please choose location

Chesterfield, Missouri Clinical Trials

A listing of Chesterfield, Missouri clinical trials actively recruiting patient volunteers.

RESULTS

Found (213) clinical trials

Nutritional Supplements on Blood Pressure 2008

Hypertensive participants will be randomly assigned into three groups. The first group of participants will take the fruits and vegetable powders mixed with water. The second group takes whey protein and the third group takes calcium pills. Blood pressure and heart rate variability will be measured every two weeks for ...

Phase

0.0 miles

Learn More »

Effect of Orthopedic Blocking on Cervical Spine Flexion and Extension Strength

All mechanoreceptor types are found in diarthrodial joints. Mechanoreceptor afferents have reflexive connections to motor neurons. Stimulation of muscle and joint afferents are known to produce reflexive muscle changes. Orthopedic blocking applies a gentle compression to the sacroiliac joints. The current study seeks to determine if orthopedic blocking of the ...

Phase N/A

0.0 miles

Learn More »

The Effects of Passive and Active Vibration Therapy on Grip Strength and Myoelectric Activity

This pilot study is designed to analyze the effects of Vibration Therapy (VT) on grip strength and level of forearm contraction by measuring hand grip dynamometry and surface Electromyography (sEMG) using the BioPac sEMG and digital dynamometry devices after the application of both passive and active Vibrational Therapy (VT) using ...

Phase

0.0 miles

Learn More »

Electrical Acupuncture and Laser Therapy for Low Back Pain

The purpose of the study is to investigate the effects of electroacupuncture and laser therapy to treat chronic low back pain.

Phase

0.0 miles

Learn More »

Effect of Electroacupuncture on Pain Threshold

This study is utilized to evaluate the what effectiveness electroacupuncture has on pain threshold as compared to sham. The outcome measurement utilized will be a digital algometer. The electroacupuncture treatment will consist of a total of four electroacupuncture treatments stimulating acupuncture points LI4 and LI11, and will be given on ...

Phase

0.0 miles

Learn More »

Study of the Efficacy and Safety of the Ranibizumab Port Delivery System (RPDS) for Sustained Delivery of Ranibizumab in Participants With Subfoveal Neovascular Age-Related Macular Degeneration (AMD) (LADDER)

This is a Phase II clinical study to evaluate the efficacy, safety and pharmacokinetics of three different formulations of ranibizumab delivered via RPDS implant compared with the standard of care (SOC) intravitreal (ITV) injections of ranibizumab, in participants with subfoveal neovascular AMD.

Phase

2.43 miles

Learn More »

Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures

This is a multicenter, open label study to assess the safety and pharmacokinetics of YKP3089 as adjunctive therapy in subjects with partial onset seizures. Initially, subjects taking phenytoin or phenobarbital will be enrolled followed by additional subjects taking anti-epileptic drugs other than phenytoin and phenobarbital to further investigate long-term safety.

Phase

2.43 miles

Learn More »

GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome

This study is a 1:1:1 randomized, double-blind, 14-week comparison of two Dose Levels of GWP42003-P versus placebo. A 28-day screening period prior to randomization (to establish baseline parameters) will precede the treatment period, which will consist of a two-week titration period followed by a 12-week maintenance period. The study will ...

Phase

2.43 miles

Learn More »

Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension

This study will evaluate the efficacy and safety of bimatoprost sustained-release (SR) in patients with open-angle glaucoma or ocular hypertension. The study includes a 12-month treatment period with an 8-month extended follow-up.

Phase

2.43 miles

Learn More »

A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis

Systemic Sclerosis (SSc) is a devastating disease of unknown etiology. Patients suffer from multiple organ fibrosis whereas lung fibrosis (interstitial lung disease, ILD) is one of the main driver for mortality. There is preclinical evidence for efficacy of nintedanib in SSc and associated ILD (SSc-ILD) and the anti-fibrotic efficacy of ...

Phase

2.43 miles

Learn More »